nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—DRD2—attention deficit hyperactivity disorder	0.682	1	CbGaD
Ketamine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0112	0.0823	CbGeAlD
Ketamine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00594	0.0437	CbGeAlD
Ketamine—GRIN2C—forebrain—attention deficit hyperactivity disorder	0.0045	0.0332	CbGeAlD
Ketamine—GRIN2D—forebrain—attention deficit hyperactivity disorder	0.00418	0.0308	CbGeAlD
Ketamine—GRIN3A—forebrain—attention deficit hyperactivity disorder	0.00393	0.029	CbGeAlD
Ketamine—GRIN1—forebrain—attention deficit hyperactivity disorder	0.00373	0.0275	CbGeAlD
Ketamine—GRIN2B—forebrain—attention deficit hyperactivity disorder	0.00356	0.0262	CbGeAlD
Ketamine—TACR1—forebrain—attention deficit hyperactivity disorder	0.00341	0.0251	CbGeAlD
Ketamine—GRIN2A—forebrain—attention deficit hyperactivity disorder	0.00311	0.0229	CbGeAlD
Ketamine—OPRD1—forebrain—attention deficit hyperactivity disorder	0.00277	0.0204	CbGeAlD
Ketamine—OPRK1—forebrain—attention deficit hyperactivity disorder	0.00266	0.0196	CbGeAlD
Ketamine—GRIN1—midbrain—attention deficit hyperactivity disorder	0.00246	0.0181	CbGeAlD
Ketamine—GRIN2C—nervous system—attention deficit hyperactivity disorder	0.00244	0.018	CbGeAlD
Ketamine—GRIN2C—central nervous system—attention deficit hyperactivity disorder	0.00235	0.0173	CbGeAlD
Ketamine—GRIN2C—cerebellum—attention deficit hyperactivity disorder	0.0023	0.0169	CbGeAlD
Ketamine—GRIN2D—nervous system—attention deficit hyperactivity disorder	0.00227	0.0167	CbGeAlD
Ketamine—GRIN2D—central nervous system—attention deficit hyperactivity disorder	0.00219	0.0161	CbGeAlD
Ketamine—GRIN2D—cerebellum—attention deficit hyperactivity disorder	0.00214	0.0157	CbGeAlD
Ketamine—GRIN3A—nervous system—attention deficit hyperactivity disorder	0.00214	0.0157	CbGeAlD
Ketamine—GRIN3A—central nervous system—attention deficit hyperactivity disorder	0.00206	0.0151	CbGeAlD
Ketamine—GRIN2A—midbrain—attention deficit hyperactivity disorder	0.00205	0.0151	CbGeAlD
Ketamine—GRIN1—nervous system—attention deficit hyperactivity disorder	0.00202	0.0149	CbGeAlD
Ketamine—GRIN1—central nervous system—attention deficit hyperactivity disorder	0.00195	0.0144	CbGeAlD
Ketamine—GRIN2B—nervous system—attention deficit hyperactivity disorder	0.00193	0.0142	CbGeAlD
Ketamine—GRIN1—cerebellum—attention deficit hyperactivity disorder	0.0019	0.014	CbGeAlD
Ketamine—OPRM1—forebrain—attention deficit hyperactivity disorder	0.00189	0.0139	CbGeAlD
Ketamine—GRIN2C—brain—attention deficit hyperactivity disorder	0.00187	0.0138	CbGeAlD
Ketamine—GRIN2B—central nervous system—attention deficit hyperactivity disorder	0.00186	0.0137	CbGeAlD
Ketamine—TACR1—nervous system—attention deficit hyperactivity disorder	0.00185	0.0136	CbGeAlD
Ketamine—GRIN2B—cerebellum—attention deficit hyperactivity disorder	0.00182	0.0134	CbGeAlD
Ketamine—TACR1—central nervous system—attention deficit hyperactivity disorder	0.00178	0.0131	CbGeAlD
Ketamine—GRIN2D—brain—attention deficit hyperactivity disorder	0.00174	0.0128	CbGeAlD
Ketamine—GRIN2A—nervous system—attention deficit hyperactivity disorder	0.00169	0.0124	CbGeAlD
Ketamine—GRIN3A—brain—attention deficit hyperactivity disorder	0.00163	0.012	CbGeAlD
Ketamine—GRIN2A—central nervous system—attention deficit hyperactivity disorder	0.00162	0.012	CbGeAlD
Ketamine—GRIN2A—cerebellum—attention deficit hyperactivity disorder	0.00159	0.0117	CbGeAlD
Ketamine—GRIN1—brain—attention deficit hyperactivity disorder	0.00155	0.0114	CbGeAlD
Ketamine—OPRD1—nervous system—attention deficit hyperactivity disorder	0.0015	0.0111	CbGeAlD
Ketamine—GRIN2B—brain—attention deficit hyperactivity disorder	0.00148	0.0109	CbGeAlD
Ketamine—OPRD1—central nervous system—attention deficit hyperactivity disorder	0.00145	0.0107	CbGeAlD
Ketamine—OPRK1—nervous system—attention deficit hyperactivity disorder	0.00144	0.0106	CbGeAlD
Ketamine—TACR1—brain—attention deficit hyperactivity disorder	0.00141	0.0104	CbGeAlD
Ketamine—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.00139	0.0102	CbGeAlD
Ketamine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00138	0.0102	CbGeAlD
Ketamine—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.00136	0.01	CbGeAlD
Ketamine—GRIN2A—brain—attention deficit hyperactivity disorder	0.00129	0.0095	CbGeAlD
Ketamine—DRD2—forebrain—attention deficit hyperactivity disorder	0.00126	0.00929	CbGeAlD
Ketamine—OPRM1—midbrain—attention deficit hyperactivity disorder	0.00125	0.00919	CbGeAlD
Ketamine—OPRD1—brain—attention deficit hyperactivity disorder	0.00115	0.00847	CbGeAlD
Ketamine—OPRK1—brain—attention deficit hyperactivity disorder	0.0011	0.00812	CbGeAlD
Ketamine—OPRM1—nervous system—attention deficit hyperactivity disorder	0.00103	0.00756	CbGeAlD
Ketamine—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.000988	0.00728	CbGeAlD
Ketamine—PTGS1—forebrain—attention deficit hyperactivity disorder	0.000922	0.00679	CbGeAlD
Ketamine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000862	0.00635	CbGeAlD
Ketamine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000854	0.00629	CbGeAlD
Ketamine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000833	0.00613	CbGeAlD
Ketamine—OPRM1—brain—attention deficit hyperactivity disorder	0.000784	0.00578	CbGeAlD
Ketamine—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.000779	0.00574	CbGeAlD
Ketamine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000751	0.00553	CbGeAlD
Ketamine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000723	0.00533	CbGeAlD
Ketamine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000685	0.00504	CbGeAlD
Ketamine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000659	0.00486	CbGeAlD
Ketamine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000644	0.00475	CbGeAlD
Ketamine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000574	0.00423	CbGeAlD
Ketamine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000554	0.00408	CbGeAlD
Ketamine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000545	0.00402	CbGeAlD
Ketamine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000533	0.00393	CbGeAlD
Ketamine—DRD2—brain—attention deficit hyperactivity disorder	0.000523	0.00385	CbGeAlD
Ketamine—PTGS1—nervous system—attention deficit hyperactivity disorder	0.0005	0.00369	CbGeAlD
Ketamine—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.000482	0.00355	CbGeAlD
Ketamine—CYP2C8—brain—attention deficit hyperactivity disorder	0.000472	0.00348	CbGeAlD
Ketamine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000461	0.0034	CbGeAlD
Ketamine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000423	0.00312	CbGeAlD
Ketamine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000418	0.00308	CbGeAlD
Ketamine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000402	0.00296	CbGeAlD
Ketamine—PTGS1—brain—attention deficit hyperactivity disorder	0.000383	0.00282	CbGeAlD
Ketamine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00036	0.00265	CbGeAlD
Ketamine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000296	0.00218	CbGeAlD
Ketamine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000285	0.0021	CbGeAlD
Ketamine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000278	0.00205	CbGeAlD
Ketamine—ABCB1—brain—attention deficit hyperactivity disorder	0.000226	0.00167	CbGeAlD
Ketamine—TACR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000119	0.000655	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000119	0.000654	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000119	0.000651	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000116	0.000639	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000115	0.00063	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000113	0.000623	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000113	0.000621	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000112	0.000617	CbGpPWpGaD
Ketamine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000112	0.000613	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000111	0.00061	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000111	0.000608	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00011	0.000605	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000107	0.000589	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000107	0.000589	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000107	0.000586	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000106	0.00058	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.000579	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000105	0.000576	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000104	0.000572	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000104	0.000572	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000104	0.000571	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000104	0.000569	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000103	0.000567	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000103	0.000566	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000103	0.000566	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000101	0.000554	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.9e-05	0.000544	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	9.83e-05	0.00054	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.71e-05	0.000533	CbGpPWpGaD
Ketamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	9.62e-05	0.000528	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	9.59e-05	0.000526	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	9.56e-05	0.000525	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	9.52e-05	0.000522	CbGpPWpGaD
Ketamine—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	9.46e-05	0.000519	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	9.44e-05	0.000518	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.2e-05	0.000505	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	9.17e-05	0.000503	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	9.12e-05	0.0005	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	9.09e-05	0.000499	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.08e-05	0.000498	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	9.03e-05	0.000496	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.93e-05	0.00049	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.66e-05	0.000475	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	8.6e-05	0.000472	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	8.45e-05	0.000464	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.43e-05	0.000462	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.4e-05	0.000461	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	8.38e-05	0.00046	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.36e-05	0.000459	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	8.28e-05	0.000454	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	8.25e-05	0.000453	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	8.22e-05	0.000451	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	8.18e-05	0.000449	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	8.15e-05	0.000447	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	8.13e-05	0.000446	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.05e-05	0.000442	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	8.05e-05	0.000442	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	8.04e-05	0.000441	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	8.04e-05	0.000441	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8e-05	0.000439	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.97e-05	0.000437	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	7.95e-05	0.000436	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.9e-05	0.000433	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.9e-05	0.000433	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	7.89e-05	0.000433	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.81e-05	0.000429	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.8e-05	0.000428	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.8e-05	0.000428	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.75e-05	0.000425	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	7.71e-05	0.000423	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.71e-05	0.000423	CbGpPWpGaD
Ketamine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.7e-05	0.000422	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	7.67e-05	0.000421	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.66e-05	0.00042	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.65e-05	0.00042	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.57e-05	0.000415	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	7.43e-05	0.000408	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	7.41e-05	0.000407	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	7.4e-05	0.000406	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	7.36e-05	0.000404	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	7.31e-05	0.000401	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	7.24e-05	0.000397	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	7.22e-05	0.000396	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	7.2e-05	0.000395	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	7.18e-05	0.000394	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.09e-05	0.000389	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	7.06e-05	0.000387	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	7.05e-05	0.000387	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.05e-05	0.000387	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7e-05	0.000384	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.97e-05	0.000382	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.92e-05	0.00038	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.88e-05	0.000378	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.8e-05	0.000373	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.77e-05	0.000371	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.74e-05	0.00037	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.73e-05	0.000369	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	6.72e-05	0.000369	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.52e-05	0.000358	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.49e-05	0.000356	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	6.41e-05	0.000352	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	6.33e-05	0.000347	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.26e-05	0.000344	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.12e-05	0.000336	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.09e-05	0.000334	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.07e-05	0.000333	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.07e-05	0.000333	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.96e-05	0.000327	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.96e-05	0.000327	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.89e-05	0.000323	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.89e-05	0.000323	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.85e-05	0.000321	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.84e-05	0.000321	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.69e-05	0.000312	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	5.58e-05	0.000306	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.51e-05	0.000302	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.49e-05	0.000301	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EP300—attention deficit hyperactivity disorder	5.42e-05	0.000298	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.41e-05	0.000297	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.37e-05	0.000295	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.35e-05	0.000293	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.3e-05	0.000291	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EP300—attention deficit hyperactivity disorder	5.29e-05	0.00029	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	5.18e-05	0.000284	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.15e-05	0.000283	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.15e-05	0.000282	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.11e-05	0.00028	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.11e-05	0.00028	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.11e-05	0.00028	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.08e-05	0.000279	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.98e-05	0.000273	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.94e-05	0.000271	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.89e-05	0.000268	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.88e-05	0.000268	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.75e-05	0.00026	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.71e-05	0.000258	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.64e-05	0.000254	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.63e-05	0.000254	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.61e-05	0.000253	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.6e-05	0.000252	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.55e-05	0.000249	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	4.53e-05	0.000249	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.52e-05	0.000248	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.52e-05	0.000248	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.46e-05	0.000245	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.43e-05	0.000243	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	4.39e-05	0.000241	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	4.32e-05	0.000237	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.31e-05	0.000237	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	4.28e-05	0.000235	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	4.26e-05	0.000234	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	4.19e-05	0.00023	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.19e-05	0.00023	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.17e-05	0.000229	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.13e-05	0.000227	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	4.13e-05	0.000227	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	4.12e-05	0.000226	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.1e-05	0.000225	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.05e-05	0.000222	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.98e-05	0.000218	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.97e-05	0.000218	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.92e-05	0.000215	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.85e-05	0.000211	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.84e-05	0.000211	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.83e-05	0.00021	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.78e-05	0.000208	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.74e-05	0.000205	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.61e-05	0.000198	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.59e-05	0.000197	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.49e-05	0.000191	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.48e-05	0.000191	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.42e-05	0.000187	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.36e-05	0.000184	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.35e-05	0.000184	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	3.29e-05	0.000181	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.25e-05	0.000179	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.2e-05	0.000176	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	3.2e-05	0.000175	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.2e-05	0.000175	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.19e-05	0.000175	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.19e-05	0.000175	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.16e-05	0.000173	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	3.14e-05	0.000173	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.13e-05	0.000172	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.94e-05	0.000161	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.92e-05	0.00016	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.91e-05	0.00016	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.78e-05	0.000153	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.74e-05	0.00015	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	2.71e-05	0.000149	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.71e-05	0.000149	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	2.66e-05	0.000146	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.64e-05	0.000145	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.62e-05	0.000144	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.56e-05	0.00014	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.55e-05	0.00014	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	2.54e-05	0.000139	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.52e-05	0.000138	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.48e-05	0.000136	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.47e-05	0.000135	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.44e-05	0.000134	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.44e-05	0.000134	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.43e-05	0.000134	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.42e-05	0.000133	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.39e-05	0.000131	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.36e-05	0.000129	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.36e-05	0.000129	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.32e-05	0.000127	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	2.2e-05	0.000121	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.2e-05	0.000121	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	2.17e-05	0.000119	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.16e-05	0.000119	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.16e-05	0.000118	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.1e-05	0.000115	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.06e-05	0.000113	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.06e-05	0.000113	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.01e-05	0.000111	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	1.94e-05	0.000106	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.92e-05	0.000106	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.88e-05	0.000103	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.79e-05	9.85e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.76e-05	9.66e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.68e-05	9.2e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	1.64e-05	9e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	1.63e-05	8.93e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.58e-05	8.66e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.56e-05	8.57e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.47e-05	8.09e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.45e-05	7.97e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.45e-05	7.97e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.43e-05	7.84e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	1.43e-05	7.84e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.42e-05	7.78e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.33e-05	7.32e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.33e-05	7.29e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.33e-05	7.27e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.29e-05	7.09e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.28e-05	7.05e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.16e-05	6.37e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.11e-05	6.07e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.09e-05	5.99e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	1.09e-05	5.97e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.8e-06	4.83e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.74e-06	4.8e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	8.31e-06	4.56e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.27e-06	4.54e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	7.03e-06	3.86e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	6.13e-06	3.36e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	5.72e-06	3.14e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.77e-06	2.07e-05	CbGpPWpGaD
